Viewing Study NCT05091333


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2025-12-31 @ 10:08 PM
Study NCT ID: NCT05091333
Status: COMPLETED
Last Update Posted: 2025-05-14
First Post: 2021-09-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: FASENRA Regulatory Postmarketing Surveillance in Korea
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module